IDM Pharma, Inc. (IDMI)

[bowonwing]

IDM @ $1.81 on 3/31/09, down from $2.51 on Thursday 3/26. Well, at least we know what the catalyst was, putting the FDA reconsideration on hold, Imho. (I knew I should not have posted those resistance levels, actually when we broke $2.21 last Friday I knew we were in trouble).

We are witnessing the greatest financial delveraging since the end of WWII, and in this financial environment I do not think the sale of the company is appropriate, unless the sale price is >$8.50 per share. 28.35M shares outstanding x $8.50= $241M market cap.

Yet the current management is seeking advice to do just that, sell the company. So, my fear that current executive management and the BofD put IDM behind the eight ball, and in an inferior bargaining position seems to have come to pass, unfortunately. Lord knows I hope I am wrong.

I agree with cybear on the Yahoo mb, right now the best thing for IDM S/H's would be that the company partner and/or finance to produce and sell MEPACT itself, in which some posters projected based on x3 revs, IDM's value at about $6.00 a share.

I know this means much more time to realize S/H value, but anything <$8.50 a share in a buyout would be to low, and what about IDM 2101??. Jmho. Glta.